Generic Name: Aflibercept
Brand Name: Eylea
Manufacturer: Bayer Inc.
Therapeutic Area: Macular edema, central retinal vein occlusion
Indications: Macular edema secondary to central retinal vein occlusion
Submission Type: New Indication
Project Status: Complete
Date Recommendation Issued: May 7, 2015
Recommendation Type: List with clinical criteria and/or conditions